Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanism of HA35 in Patients With Alcoholic Liver Disease

NCT05018481 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT05018481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05018481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanism of HA35 in Patients With Alcoholic Liver Disease
Lead sponsor
The Cleveland Clinic
Phase
Phase 1
Overall status
Recruiting
Start date
September 1, 2022
Completion date
October 1, 2028
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic hepatitis